XIDX
AGII
Market cap238mUSD
Nov 12, Last price
1,405.00IDR
Name
Samator Indo Gas Tbk PT
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Aneka Gas Industri Tbk, an Indonesian enterprise, specializes in the production, distribution, and sale of a diverse array of industrial gases. Its extensive product line includes common atmospheric gases like oxygen, nitrogen, and argon. The company also supplies a range of specialized and mixed gas formulations, such as sulfur hexafluoride, high-purity gases, sterilization agents, compressed natural gas, environmental calibration mixtures, and gases tailored for exhaust emissions engine analysis. Synthetic gases like hydrogen, carbon monoxide, and sulfur dioxide are also part of its offerings. For the healthcare sector, the company provides medical oxygen, nitrous oxide, medical air, nitrogen, carbon dioxide, helium, lung function testing mixtures, blood analysis calibration gases, and cryopreservation gases. Furthermore, hydrocarbon gases including propane, natural gas, liquefied petroleum gas (LPG), and acetylene are available. Additional products encompass ammonia, proprietary Samator fuel gas, and rare atmospheric gases such as krypton, neon, and xenon. Beyond gases, the company offers a suite of related products and services, including medical equipment and supplies, advanced medical gas monitoring systems, on-site gas generation solutions, gas handling and cutting tools, and modular operating theater components. Comprehensive installation services are also provided. Operations are supported by a network of approximately 100 gas filling stations. Established in 1916, this venerable enterprise maintains its headquarters in Jakarta Selatan, Indonesia.
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||